Saturday, February 9, 2013

Global Recognition For Aanjaneya Lifecare, Enters The Elite List of Golden Peacock Awards, Receives “Golden Peacock National Quality Award’


Global Recognition For Aanjaneya Lifecare, Enters The Elite List of Golden Peacock Awards, Receives “Golden Peacock National Quality Award’
Aanjaneya Lifecare Selected in Pharmaceutical Sector For Robust Growth, Corporate Governance & Innovative Business Approach in tough Market Conditions.
India. Maharashtra, Mumbai, Saturday, 9th Feb 2013. Mumbai-based Aanjaneya Lifecare Limited BSE code (533412), the vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments, has received yet another feather in its cap at Golden Peacock National Quality Award – 2012 by winning the coveted title in Bangalore on 8th Feb 2013 in the presence of distinguished gathering of business leaders, jurists, academics, environmentalists, economists, legislators and policy makers during the 23rd World Congress on Leadership and Quality of Governance,. Aanjaneya Lifecare Ltd' has been selected as the winner of the ‘Golden Peacock National Quality Award’  on account of its formidable growth momentum under tough business environment for the year 2012 by the Awards Jury under the Chairmanship of Justice P. N. Bhagwati, former Chief Justice of India and Member, UN Human Rights Commission, Justice M N Venkatachaliah, chairman, IOD Advisory Council & former Chief Justice of India were among the judging panel for this year's Golden Peacock Awards. BRAND image was among the most important criteria in the selection process. The Prestigious Award was conferred at a glittering award evening by Justice M N Venkatachaliah, Former Chief Justice of India at a power packed audience at Hotel Lalit Ashoka, Bangalore. The Coveted Award was received by Mr Kashi Vishwanath, Chairman of Aanjaneya Lifecare Ltd.
On Friday, Aanjaneya declared the First 9 months report card where The Net Profit of Aanjaneya Lifecare Limited rose 8.19% to Rs 387.22 million in the first nine months ended 31st December 2012 as against Rs 357.91 million during the corresponding period of the last year. Total Sales during the first nine months ended 31st December 2012 was up 40.16% at Rs 4468.46 million as against Rs 3188.12 million for the same period last year.
Speaking on the Award, Dr Kannan Vishwanath, Vice-Chairman & Managing Director, Aanjaneya Lifecare Ltd said “  This coveted title of Golden Peacock National Quality Awards reflect the resounding success of Aanjaneya Lifecare in the Pharmaceutical Industry in a short span of time & meeting the tough global challenges of keeping the winning Momentum, This Award is a standing testimony of the entire Aanjaneya Lifecare’s internal & external stakeholders who have reposed faith in our Organization”.   While we are elated to receive this rare distinction, our responsibility increases manifold as the road ahead are full of challenges & plethora of opportunities Dr Kannan added. The award is a validation for our innovative tool used to predict results and plan results with appropriate action plans is Scientific, Logical and well accepted and rightly acknowledged by a reputed team of assessors and distinguished Jury.". The Golden Peacock Awards were initiated by Institute of Directors, an apex association of Directors, in 1991. The Golden Peacock Awards Secretariat receives over 1000 entries each year for various awards, from over 25 countries worldwide. The Golden Peacock Awards is a set of prestigious national and global awards designed to improve productivity and quality in organizations.
About Aanjaneya Lifecare Limited:
Aanjaneya Lifecare Limited is a vertically integrated company having state-of-the-art; WHO GMP approved facilities for manufacturing bulk drugs at Mahad and finished dosage forms at Pirungut near Pune. It is one of the largest contract manufacturers of codeine based cough syrups in India. The company exclusively manufactures the Codorex Brand of Zydus Cadilla and Codilite Brand of Tablets India Ltd. amongst others.The company raised about Rs. 117 crore from its IPO and the funds are being used to built new capacities along with the refurbishing of Research & Development centre. The new facilities being created as part of CAPEX are using eco friendly, recyclable material and will be rated by LEEDS once completed.The Facilities being established will comply with the latest European & US guidelines. With new capacities to be added in next 6 to 9 months the company will be expanding operations in emerging markets of South East Asia, Africa & South & Central America and its domestic operation in branded generics segment.
The company with its manufacturing facilities –in Mahad, Hyderabad and Pune has to its credit many achievements.

Ø      It is the world’s third-largest manufacturer of quinine salts in the world . Only nine companies globally manufacture quinine salts.
Ø      One of the largest codeine based formlulations manufacturer in the pharmaceutical sector
Ø      One of the largest manufacturer of multi- flavored Lozenges in  medical products in India
Ø      The company pioneered the recognition that lozenges represent a stable platform for the delivery of pharmaceutical and nutraceutical ingredients
Ø      Anjaneya’s Nicco Nil lozenge is a first-of-its-kind  hard boiled lozenge remedy for smoking de-addition; its Relacs is a first-time lozenge against insomnia and Arecta Plus, a lozenge variant for Erectile Dysfunction, is a first of its kind .

The company has an expertise in opportunity spotting and innovation. The company’s success has been built on a business model that integrates Research, Innovation and Knowledge. The company has invested in building proprietary Knowledge through research and acquisitions. Anajaneyas Lifecare’s competence has been validated through patents granted by international and Indian authorities.
 Highlights 2011-2012 for Active Pharmaceutical Ingredents
Ø  Production of Quinine Sulphate increased 30% in 2011-2012
Ø  Sales of Quinine Sulphate grew 45%
Ø  Exports increased 250% from Rs 10 Crore to Rs 31 crore
Ø  Added 35 international and 50 domestic clients
Ø  Completed trials for Bromexine(expectorant)a new API that will be launched in 2012-1023
Highlights 2011-2012 for Finished Dosage Forms
Ø  Launched 'Rancorex' an in-house codine based cough syrup brand for the first time in its history
Ø  received the Kenya PPB GMP approval from all facilities namely lozenges,liquids and iontments
Ø  Received registration for 'Arecta Plus'(a lozenge variant of Viagra tablets)from Sierrs Leone and Libya; received the first export order for this product to be executed in 2012-2013.

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage
Ind

    

Skincare Treatment Will Soon Become Affordable To Rising Indian Middle-Class – Dr Nilayini of Blu Skin & Cosmetology


Skincare Treatment Will Soon Become Affordable To Rising Indian Middle-Class – Dr Nilayini of Blu Skin & Cosmetology

09FEB

Skincare Treatment Will Soon Become Affordable To Rising Indian Middle-Class – Dr Nilayini  of Blu Skin & Cosmetology
With the increasing stress levels, mirrored with an escalation in pollution, both outdoors and indoors, the incidence of skin ailments is on the increase! And most of these conditions can have an effect of incapacitation on the person enduring the skin problem                  

 With the increasing focus on enhancing beauty care coupled with latest innovations in skincare treatment, the Indian Wellness Market has grown by leaps & bounds. It is no secret that a quite a sizeable chunk of urban as well as Semi Urban market in India is witnessing the emergence of “New Look Woman’ as well as ‘Extra & Enhanced Beauty Care for Men’ as they set to make their presence in their professional life to look different & add a persona. While the traditional concept of treatment is still in practice, the mood of the nation seems certainly signaling a metamorphosis. The need to add extra impression seems to redefine the whole concept of looking good. The wider treatment such as Botox,Fillers,Chemical Peels,Skin Polish,Microneedling,Acne Scars,Acne,Hydrafacial,Laser Hair Removal,Skin Tightening,Wrinkles & Lines,Skin Brightening,Skin Hydration,Microdermabrasion,RF Refirme Treatment,Dermaroller Therapy,Mesotherapy,Pumpkin Peel,Vit C Peel,Body Clinic,Laser Hair Removal,Tan Removal,Skin Polish,Enzyme Polish,Scar Removal,Decollete / Neck,Hands Feet,Elbows & Knees,Stretch Marks,Warts/Skin Tags,Mole Removal,Lipo-Dissolve,Platelet Rich Plasma Therapy,Scar & Stretch Marks Treatment,Hair Clinic,Dandruff,Hair Loss,Stem Cell Therapy,Psoriasis,Hair Transplantation,Super Laser Hair Removal has dominated the beauty care market. More & More Dermatologists are increasingly feeling their space in cosmetic care as it gives great earnings as well as newer experimentation. Of late we have witnessed more & more Doctors want to pursue Derma, Cosmetic & Hair Plant course post their MBBS. While many prefer overseas institutions to fulfill their training needs, Indian institutions remain more cost effective to their basic choice. Today’s Dermatologists & Cosmetologists are no more confined to their basic skincare needs, but has expanded into latest high-tech labs for beauty care treatment. It seems sometimes that it has become a necessity than luxury though the subject still needs a wider debate as the cost component is a major deterrent feels Satya Brahma, Editor-In-Chief of Pharmaleaders Magazine. India is a unique Market quite compared to the western market which is dominated by lifestyle needs to glow up their skin, In India, though price is a major factor, the skincare market is certainly growing very big & given the present scenario where looks dominate merit (mostly), the role of Dermatologists & Cosmetologists are increasingly becoming challenging & ever demanding as The skin care market is valued at Rs 400 crore for 2012 and is growing at a CAGR of 15 per cent, Satya added.  
To understand what drives the mindset of the people’s perception, Pharmaleaders spoke to Dr Nilayini, the founder of South India’s one of the most sophisticated state of the art centre, Blu Skin & Cosmetology  which also has a Spa. In an exclusive Interview to Satya Brahma, Editor-In-Chief of Pharmaleaders, Dr Nilayinispoke on wide ranging topics of the past, present & gradual evolution of the skincare industry & its treatment process. Dr Nilayini,Founder,M.B.B.S,DD (Dermatology)(UK), is the prestigious member of American Society of Aesthetic and Cosmetic Physicians. Dr. Nilayini has been accredited nationally and internationally in various advanced cosmetic procedures like Fillers and Botox. She started Blu Skin & Cosmetology – the first of its kind, in the high profile area of Hyderabad ie Jubilee Hills, an abode to many niche clients in and around Hyderabad and from other cities & countries. Blu Skin & Cosmetology is the pioneer among the Beauty Medical Spas in Hyderabad, in terms of facilities , infrastructure & services offered. Blu Skin & Cosmetology was inaugurated by the legendary actor Akkineni Nagarjuna. The aesthetic caliber that Dr Nilayini possesses is far beyond questioning , and with the patient success reviews she gets about Blu Skin & Cosmetology, it is beyond doubt that she is the prime & hard force in the reckoning, especially in the field of aesthetic cosmetology.
Excerpts from the Interview.
PL : Is skincare treatment a Luxury or a Necessity?
The common perception that it is a luxury, which probably was true to a major extent! However, with the increasing stress levels, mirrored with an escalation in pollution, both outdoors and indoors, the incidence of skin ailments is on the increase! And most of these conditions can have an effect of incapacitation on the person enduring the skin problem. The good news is that a majority of these skin conditions can be cured with medications and evidence-based interventions, thereby not only reducing and limiting the morbid situations but also increasing the quality of life!
So, what used to be a luxury, is now a necessity in not only persons whose occupation demands a flawless skin (personnel belonging to hospitality industry, theatre and movie industry, aviation industry personnel and receptionists)  but also in persons who are enduring various skin ailments.
PL.      The Market for Skincare or Beauty care is increasing. Do you feel the Price war with your competitor Skin Specialists?
Skin care is wrongly perceived as being “expensive” and the same care will be made available at a lesser price elsewhere! The truth of the matter is, like in all professions, providing a high standard of care and therapy needs investment in equipment that is of international standards, and more importantly ratified authorities such a USFDA.    Centers that provide such quality of care are very few in our country, so the issue of ‘price war’ is of lesser importance when compared to providing safe and state of art care!
PL. Is Hyderabad a Perfect Market for a Celebrity Cosmetologist?
Hyderabad is the fourth most populous city in India and also boosts a higher sex ratio compared to the national average! The health awareness is on the rise, thanks to the blooming IT centers and also to the fact that Hyderabad hosts only the umpteen numbers of national and multinational companies, in addition to the telugu-film industry, which produces the largest number of motion-pictures in India! Therefore, Hyderabad has the potential to be a ‘perfect market’ for celebrity cosmetologists!
PL : When did you Conceive Blu Skin & Cosmetology, Was there a need?
‘Blu’ was conceived when I was a medical student. After qualifying as a doctor, I felt the need to have an overview of all the various disciplines, therefore, after gaining adequate experience in the major medical fields; I achieved my immediate objective of starting a skin and cosmetology clinic in 2009. Having made a niche as a preeminent center, my secondary objective is to evolve Blu into the best Skin and Cosmetology center in the country!
PL.      Has Indian Middle Class Woman come of ages & Ready to spend extra Pound to look Beauty?
Our present ‘middle class’ is expected to reach or cross 40% (or > 500 million) of our vast population. With India witnessing one of the fastest growth in economies, even the purchasing power parity is expected to increase from 4.7% to 6.1% of the world share by 2015. Given these facts, the average Indian middle class woman is surely on her way to state of increased awareness of all-round and has the potential to spend the extra rupee on looking ‘good’, thereby increasing their self-esteem!
PL.      What is your take on Laser Hair Removal VS Bikini Waxing?
LHR is a medical procedure where as bikini waxing is not. LHR is carried out by a certified professional. LHR is long lasting results, safer and less painful than bikini waxing. Apart from all this it greatly cost effective. Whereas bikini waxing poses a lot of health hazards, like infections and side effects.
PL.      Do you have plans to spread your Clinic all India, If so when & How?
As I have already mentioned, having achieved the objective of starting Blu, the second objective is to evolve and progress to being the best in the business!  Once I achieve this secondary objective (which I believe that we are on our way), we then will look at the third objective of establishing more centers in other cities across India.
PL.      How can you see you are offering a different treatment than others?
Our treatments are more personal and specific. We do not believe in quantity we believe in Evidence & quality based medicine moreover the safety procedures are adapted by us is one of its kind.
PL.      What is the most common myth about acne?
That it is “curable”! Acne, though a common physiological consequence, can be controlled to a significant extent, by a comprehensive approach. This involves a detailed assessment comprising of going into the life-style, diet, family history, medication history, allergies  and associated hormonal imbalances, if any.                    In most of the cases, acne can be controlled and cured, though not in all the cases.
PL.      When did you first know you wanted to create your own line of beauty Clinic?
Like I said earlier, I always felt that I can do more here because the idea of making someone look more beautiful was very exciting to me. This realization happened during my student years.
PL.      How did you garner such a celebrity following?
By inflexible adherence to quality of care that we impart and provide to all our clients. In fact, all our interventions are under the aegis of evidence-based practices, most of which have evolved after vigorous clinical trials. 
PL.      Can you share some beauty tips that every woman should know?
I believe every person born beautiful! The only way to maintain this God’s given endowment is to follow a healthy lifestyle, which comprises consuming proper diet and imbibing adequate non-alcoholic and non-caffeine containing fluids, adequate physical activity and regular exercise, and getting adequate sleep. Some persons have skin types which are more prone to rashes, pigmentation and eruptions, which can be prevented or controlled to a significant extent by avoid direct exposure to sun and using sun-screens with an SPF of 25 or more.  
PL.      What is the secret to great looking skin?
In addition to the above, there are other ways are to avoid smoking and highly polluted environments. Avoid the day-today stresses from becoming severe by taking up meditation or an active hobby!
PL.      What ingredients do you recommend that make a difference? What is the main ingredient to look for other than benzyl peroxide? What difference do over the counter creams and lotions make to common acne?
I recommend Retinoic acid 0.50%, OTC may work in mild cases but for moderate to severe with some underlying causes it is may actually worsen therefore it is always advised to consult a doctor
Would you ever advise hormone control or the pill to younger women? What should a dermatologist do before prescribing treatment?
After the through check up of the patient ruling out any possible risk factors and after clinical and laboratory investigations and also the opinion taken from the specialty doctor of the client Hormone control pills can be prescribed to younger woman. Before prescribing a derm has to take safety procedures
PL.      Celebrities seem to be perfect. The right figure, skin, eyes, make up, hair etc and with no amount of effort do we get to own the same. Why? The reason is lack of dedication and demand. Celebrities can’t afford to look bad, thus they are dedicated to their regime but there is also the concept of celebrity beauty secrets. Each one has one secret to their perfect beauty, which makes them different from the common mass. What is your take on this?
The way the celebrities take care of their body and skin is entirely different, which a common man cannot maintain in his day-to-day activity, most of it is also a combination of genes and compliance. What they have achieved is only due to a lot of dedication and practice. Having said this, there is an individual decision and thorough effort that goes into differentiating a celebrity from a common man.
Looking perfect is a part of their profession and it’s a necessity for them to be conscious and careful about what their appearance is and this differentiates them from the common people, in case of common people , it’s their choice, it’s the way how the individual wants.
PL.      How will you sum up about yourself as a Doctor & as an Individual?
As a medical doctor I follow the dictum of  “primun non nocere” i.e., first of all, do no further harm! My medical training puts be in a position to completely assess the person’s medical status, with a view of tolerance or intolerance of the planned therapy, and the possible outcome. Only after a thorough assessment, that we commence our interventions. As an individual, it is an immense satisfaction to note that all my clients have a postitve outcome and I have contributed in  a way to their happiness!
PL.  Do you feel Slimming Tablets can make a Difference in reducing Extra Weight?
There are established guidelines for medication therapy in weight management and when administered under controlled conditions, they achieve the objective of weight reduction. Therefore, the slimming pills have a definite role, if the person falls in this category. In some cases, they have to be taken over a prolonged periods of time. 
PL.  What are your views on Breast Implants, How Big the market is?
Breast implants is a personal decision that is entirely on the patients call. If it changes her life to a significant extent, in her perception, then so be it! The very fact that the demand for breast augmentation is on the increase in India confirms my point.
PL.  What are the complications you have faced while starting your career?
It was a big challenge – as I was the first to start on my own and at a stage where my experience in the economics involved was in its infancy. In addition, Hyderabad market was new to this type of care. However, my learning curve was not a prolonged one, and very soon I got the penchant to assess and impart therapy and also manage the business angle of running Blu!
PL.  Would you like to be called as a Millionaire Skincare Specialist?
We stile to impart evidence-based care to all our cliImageImageImageImageImageents and aim to make a positive-change in their lives! Therefore, I would rather like to known as a skincare specialist who made a difference to a million lives.  
                                       ImageImageImageImageImageImageImageImageImageImageImageImage

Thursday, January 17, 2013

Aanjaneya Lifecare Begins the Fiscal on a Strong Note, bags coveted “ Asia’s Emerging Pharmaceutical Company on Innovations Award 2013” at Assocham’s 10th Knowledge Millennium Summit.


Aanjaneya Lifecare Begins the Fiscal on a Strong Note, bags coveted “ Asia’s Emerging Pharmaceutical Company on Innovations Award 2013” at Assocham’s 10th Knowledge Millennium Summit.

Aanjaneya Lifecare Selected for the coveted & Prestigious Title for Innovations, Sustainable Corporate Ethical Practices & Significant Investors Goodwill.
India, New Delhi. January 18th, 2012: Aanjaneya Lifecare Limited, India’s fastest growing Pharmaceutical Group having a proven track record of delivering consistence performances engaged in the manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms along with delivery of CRAMS has its presence in 60 countries  in the fiercely competitive domestic Contract Manufacturing Market as well as in International market with a significant leadership market presence in Quinine Salts manufacturer in the world received a rare distinction of being Asia’s Emerging Pharmaceutical Company on Innovations at a Assocham Meet today at Vigyan Bhavan in New Delhi presided by Pranab Mukherjee, The President of India. . Recently, Aanjaneya Lifecare Limited has got approval to issue Foreign Currency Convertible Bonds to eligible foreign investors amounting Rs.405 crore, the only pharmaceutical company where the Indian government has approved 14 proposals of foreign direct investment amounting to a total of Rs. 1,310.60 crore. Aanjaneya Lifecare is a focused integrated emerging pharmaceutical company in bulk drugs as well as finished dosage forms. Recently Aanjaneya Lifecare has bagged two prestigious awards by being ranked No 2 Industry wise & 9th Position in Asia- Pacific region at The Global Investor Relations (GIR) Summit  Coordinated by KPMG and MZ associates. Organised byThe Associated Chambers of Commerce and Industry of India (ASSOCHAM), India's premier apex chamber covers a membership of over 4 lakh companies and professionals across the country. It was established in 1920 by promoter chambers, representing all regions of India today conferred the prestigious Asia’s Emerging Pharmaceutical Company on Innovations Award 2013 in a power packed gatherings of the industry captains. The Department of Science & Technology, Ministry of Science & Technology was the co-sponsor of the Event.
Speaking on the Award from Dr. S. N. Khan, Director, Department Of Science And Technology. Govt of India , Dr. Kannan Vishwanath, Vice Chairman & Managing Director of Aanjaneya Lifecare Limited said “This is a rare distinction & has a significant bearing on all our future initiatives, as a Corporate Entity & a responsible Company, our responsibility will increase manifold as we have wide & bigger plans ahead which we plan to achieve in the first quarter of this year. This recognition reflects our overall commitment to adhere quality norms, corporate ethics,investor relations besides our long bonding with internal & external stakeholders.” Aanjaneya Lifecare will emerge out as a leading Research driven healthcare group in the worlds as it is presently passing through a historic innovation transition, said Dr Kannan. Shri D.S.Rawat, Secretary General, ASSOCHAM said “ Aanjaneya Lifecare is fast making its foothold in the healthcare space with great speed & perfection in a short span of time, the juries looked at overall ratings in Aanjaneya Lifecare’s commitment to society & Medical Profession”.
The event was attended by stalwarts  from policy makers, CEOs, CFOs, consultants and senior professionals from the packaging sector and allied fields.  Speakers include senior government officials, policy makers as well as leadership from the packaging industry. The Chief Guest for the event is the Honourable President of India- Shri Pranav Mukherjee. Padma Bhushan Dr. B. K. Rao, Chairman, Knowledge Millennium Committee, Ex –Chairman, Sir Ganga Ram Hospital, Prof. Aaron Ciechanover, 2004 Noble Prize Winner in Chemistry, Dr. V. M. Katoch, Secretary (Department of Health Research) & Director General, Indian Council of Medical Research (ICMR), Dr. H. K. Chopra Cardiologist Mool Chand Medcity, Shri R. N. Dhoot, Member of Parliament and President, ASSOCHAM, Shri D.S.Rawat, Secretary General, ASSOCHAM, Shri S. Jaipal Reddy, Hon’ble Minister of Science & Technology & Earth Sciences, GoI, Dr. Rana Kapoor, Sr. Vice President, ASSOCHAM & Founder, Managing Director and CEO, Yes Bank Ltd, Dr. S. N. Khan, Director, Department Of Science And Technology were among those who graced & spoke at the prestigious Event. Dr Kannan Vishwanath, Managing Director of Aanjaneya Life care delivered a talk on Innovations in Healthcare Industry : Challenges within & Outside at the Summit.

About Aanjaneya Lifecare Limited:
Aanjaneya Lifecare Limited, BSE code (533412), a Rs 490 crores, integrated pharmaceutical company engaged in the manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms along with delivery of CRAMS has its presence in 60 countries.

The company with its manufacturing facilities –in Mahad, Hyderabad and Pune has to its credit many achievements.

  • It is the world’s third-largest manufacturer of quinine salts and the second-largest in India. Only nine companies globally manufacture quinine salts. Aanjaneya is only the second company to receive WHO prequalification for its anti-malarial APIs and formulations.
  • It is one of the most cost-effective quinine manufacturers
  • One of the largest codeine quota holders in the pharmaceutical sector
  • The only manufacturer of multi- flavored Lozenge medical products in India
  • The only company in India to be classified as ethical prescription dosages for diverse therapeutic segments. It is positioned as a global Centre of Excellence in the area of Lozenge manufacture
  • The company pioneered the recognition that lozenges represent a stable platform for the delivery of pharmaceutical and nutraceutical ingredients
  • Anjaneya’s Nicco Nil lozenge is a first-of-its-kind remedy in the world for smoking de-addition; its Relacs is a first-time lozenge against insomnia in India, and Arecta Plus, a lozenge variant for Viagra, is a first for India.
The company has an expertise in opportunity spotting and innovation. The company’s success has been built on a business model that integrates Research, Innovation and Knowledge. The company has invested in building proprietary Knowledge through research and acquisitions.
Anajaneyas Lifecare’s competence has been validated through patents granted by international and Indian authorities.
Highlights 2011-2012 for Active Pharmaceutical Ingredents
  • Production of Quinine Sulphate increased 30% in 2011-2012
  • Sales of Quinine Sulphate grew 45%
  • Exports increased 250% from Rs 10 Crore to Rs 31 crore
  • Added 35 international and 50 domestic clients
  • Completed trials for Bromexine(expectorant)a new API that will be launched in 2012-1023
Highlights 2011-2012 for Finished Dosage Forms
  • Launched 'Rancorex' an in-house codine based cough syrup brand for the first time in its history
  • received the Kenya PPB GMP approval from all facilities namely lozenges,liquids and iontments
  • Received registration for 'Arecta Plus'(a lozenge variant of Viagra tablets)from Sierrs Leone and Libya; received the first export order for this product to be executed in 2012-2013
Aanjaneya Lifecare Limited, a vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments.The company is the third largest Quinine Salts manufacturer in the world.The company recently raised about Rs. 117 crore from its IPO and the funds are being used to built new capacities along with the refurbishing of Research & Development centre. The new facilities being created as part of CAPEX are using eco friendly, recyclable material and will be rated by LEEDS once completed, company sources informed. The Facilities being established will comply with the latest European & US guidelines. With new capacities to be added in next 6 to 9 months the company will be expanding operations in emerging markets of South East Asia, Africa & South & Central America and its domestic operation in branded generics segment. Landmark Awards for Aanjaneya Lifecare Ltd.
1.       India's Most technically & scientifically advanced Pharmaceutical Manufacturing unit of the year 2011 at 4th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2011
2.       Emerging Company of the Year 2011 at 4th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2011
3.       Gold Certification for its Annual Report at the LACP 2012 Global Communications Spotlight Awards Held in Florida USA
4.       India’s Most Valuable Company on “Corporate Governance, Ethical Practice & Sustainability Vision” Award at 3rd Annual India Leadership Conclave & Business Leadership Awards 2012.
5.       ‘IMC Ramakarishna Bajaj Award 2012’. one of the most prestigious Quality awards in India. The company got recognised as one of the leading and fastest growing integrated pharma companies in India.
6.       BSE Award for Best Return to Investors 2012 at 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012.
7.       Aanjaneya Lifecare Limited ranked No 2 Industry wise & 9th Position in the Asia- Pacific region at The Global Investor Relations Summit.                                                                                        

Friday, January 11, 2013

Aanjaneya Lifecare Among the 14 FDI Proposals Eligible For Rs.405 crore.


FDI proposals worth Rs.1,310 crore approved The government has approved 14 proposals of foreign direct investment amounting to a total of Rs. 1,310.60 crore

New Delhi, Jan 11: The government has approved 14 proposals of foreign direct investment (FDI) amounting to Rs.1,310.60 crore.
“Based on the recommendations of Foreign Investment Promotion Board (FIPB) in its meeting held on Dec 21, 2012, the government has approved 14 proposals of FDI amounting to Rs.1310.60 crore approximately,” the finance ministry said in a statement Friday.

The largest fund inflow is related to Mumbai-based shipping firm Hindustan Port Private Limited. The company has got approval to induct Rs.440 crore overseas fund for making downstream investment in other Indian companies.

A Mumbai-based pharmaceutical firm Aanjaneya Lifecare Limited has got approval to issue Foreign Currency Convertible Bonds to eligible foreign investors amounting Rs.405 crore.

Bangalore-based Syngene International Limited has got approval to induct Rs.125 crore foreign equity.

The government has rejected three proposals, while decision on six proposals have been deferred.

Dr Kannan Vishwanath founded Aanjaneya Lifecare Limited in 2006. He has completed his Chemical Engineering in Pune & Masters & Doctorate of Philosophy in Business Management from University of Azteca. He has over 12 years Experience in Pharmaceutical Industry with expertise in Licensing, Business Development, API, Generics, Finished Dose, Intermediates, marketing, production, distribution, licensing, outsourcing, contract development, formulation development, Patience ans Risk Taking are among the motivational factors applied by Dr Vishwanath and they have helped the company to learn from past mistakes and in making better decisions in future. A believer in fair practices, this visionary leader always offers his hand when needed regardless a friend or foe. Dr Vishwanath believes: “when you have a dream , don’t let anything dim it . Keep hoping, keep trying , for Sky is the Limit.



Coming from a very humble beginning with just 40 employees and small manufacturing facility for anti malarial drugs over 6 years ago , Dr Vishwanath has achieved exceptional results through developing and redefining the business roadmap, ensuring differentiation as a competitive advantage and clearly focusing on the brands consumers want and the products consumers need . Anjaneya Lifecare Limited (ALL )  produces & markets a range of pharmaceutical products across the globe . With two facilities in Maharashtra state employing over 300 people the company delivers essential products for every day life under the brands Rankorex, Prosils, DocTor quore, Esyhil, amongst others. The company has over 200 distributors pan India for its Branded Generic products & exports to over 40 countries with sales in excess of 320 crores. Under Dr Vishwanath’s leadership, the  marketind, reachersh & product development departments were expanded . The company has been growing at CAGR of 175 % for last 5 years and is now the third largest manufacturer of Quinine salts in world. ALL has received many awards and accolades which recognize its brands and product excellence , such as  the Green Business of the year-2011  at Emerging India Awards by ICICI  Bank & CNBC TV 18 & voted among the top 100 company in “ India’s Best  Companies to Work With -2011 “.Aanjaneya’s global accolades …position Aanjaneya it differently.   We started the tough way. We proactively institutionalised best-in-league systems and processes. And consumers around the globe vindicated our approach. The result: we are partners with a number of global pharma leaders.   We started the tough way. We proactively institutionalized best-in-league systems and processes. And the globe vindicated our approach. The result: we are partners with global pharma leaders.



About Aanjaneya Lifecare Limited:

Aanjaneya Lifecare Limited is a vertically integrated company having state-of-the-art; WHO GMP approved facilities for manufacturing bulk drugs at Mahad and finished dosage forms at Pirungut near Pune. It is one of the largest contract manufacturers of codeine based cough syrups in India. The company exclusively manufactures the Codorex Brand of Zydus Cadilla and Codilite Brand of Tablets India Ltd. amongst others.



Aanjaneya Lifecare Limited, a vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments.The company is the third largest Quinine Salts manufacturer in the world.

The company recently raised about Rs. 117 crore from its IPO and the funds are being used to built new capacities along with the refurbishing of Research & Development centre. The new facilities being created as part of CAPEX are using eco friendly, recyclable material and will be rated by LEEDS once completed, company sources informed. The Facilities being established will comply with the latest European & US guidelines. With new capacities to be added in next 6 to 9 months the company will be expanding operations in emerging markets of South East Asia, Africa & South & Central America and its domestic operation in branded generics segment.

Landmark Awards for Aanjaneya Lifecare Ltd.



  • India’s Most technically & scientifically advanced Pharmaceutical Manufacturing unit of the year 2011 at 4th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2011
  • Emerging Company of the Year 2011 at 4th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2011
  •  Gold Certification for its Annual Report at the LACP 2012 Global Communications Spotlight Awards Held in Florida USA
  • India’s Most Valuable Company on “Corporate Governance, Ethical Practice & Sustainability Vision” Award at 3rd Annual India Leadership Conclave & Business Leadership Awards 2012.
  • ‘IMC Ramakarishna Bajaj Award 2012’. one of the most prestigious Quality awards in India. The company got recognised as one of the leading and fastest growing integrated pharma companies in India.
  • BSE Award for Best Return to Investors 2012 at 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012.
  • Aanjaneya Lifecare Limited ranked No 2 Industry wise & 9th Position in the Asia- Pacific region at The Global Investor Relations Summit.
  • aanjaneya